HF Advisory Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Buy
5,518
+846
+18% +$176K 0.41% 81
2026
Q1
$987K Sell
4,672
-555
-11% -$120K 0.34% 96
2025
Q4
$1.07M Buy
5,227
+49
+0.9% +$9.22K 0.37% 91
2025
Q3
$813K Buy
5,178
+424
+9% +$65.5K 0.3% 106
2025
Q2
$799K Buy
4,754
+437
+10% +$64.9K 0.32% 103
2025
Q1
$595K Sell
4,317
-129
-3% -$16.4K 0.26% 117
2024
Q4
$526K Sell
4,446
-4,151
-48% -$485K 0.24% 119
2024
Q3
$950K Buy
8,597
+663
+8% +$69.3K 0.44% 86
2024
Q2
$780K Buy
7,934
+377
+5% +$38.4K 0.4% 92
2024
Q1
$846K Buy
7,557
+128
+2% +$13.8K 0.47% 76
2023
Q4
$749K Sell
7,429
-1,045
-12% -$104K 0.48% 76
2023
Q3
$736K Sell
8,474
-309
-4% -$27.9K 0.55% 66
2023
Q2
$831K Buy
8,783
+878
+11% +$74.2K 0.66% 58
2023
Q1
$597K Buy
7,905
+1,487
+23% +$112K 0.53% 71
2022
Q4
$493K Buy
+6,418
New +$488K 0.5% 72

Other funds holding CAH

HF Advisory Group's CAH Position: Q2 2026 in Review

HF Advisory Group increased its Cardinal Health (CAH) stake by 18% in Q2 2026, buying an estimated $176K and bringing the position to 5,518 shares worth $1.31M. The position accounts for 0.41% of the portfolio, ranked #81.

HF Advisory Group first reported a position in CAH in Q4 2022 and has held it in 15 quarters since. 375 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • HF Advisory Group held 5,518 shares of Cardinal Health worth $1.31M as of Q2 2026.
  • HF Advisory Group bought 846 Cardinal Health shares in Q2 2026, an estimated $176K.
  • Cardinal Health made up 0.41% of HF Advisory Group's portfolio in Q2 2026, its #81 holding.
  • HF Advisory Group first reported a position in Cardinal Health in Q4 2022 and has held it in 15 quarters since.
  • 375 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on HF Advisory Group's 13F filing for Q2 2026, filed 9 Jul 2026.